As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand ...
Glioblastoma is an aggressive and highly infiltrative brain tumor with a 5-y survival rate of 4% (1–3). The current standard of care, the Stupp protocol (4,5), which combines surgical resection with ...
Journal of Nuclear Medicine May 2026, jnumed.126.272191; DOI: https://doi.org/10.2967/jnumed.126.272191 ...
Brain PET is a powerful imaging modality that directly reflects cerebral metabolic activity, making it an essential tool for human brain research. However, conventional brain PET typically requires ...
Journal of Nuclear Medicine April 2026, jnumed.125.271933; DOI: https://doi.org/10.2967/jnumed.125.271933 ...
Journal of Nuclear Medicine April 2026, jnumed.125.271880; DOI: https://doi.org/10.2967/jnumed.125.271880 ...
Journal of Nuclear Medicine April 2026, jnumed.125.271565; DOI: https://doi.org/10.2967/jnumed.125.271565 ...
Journal of Nuclear Medicine April 2026, jnumed.125.270483; DOI: https://doi.org/10.2967/jnumed.125.270483 ...
Journal of Nuclear Medicine April 2026, jnumed.125.271421; DOI: https://doi.org/10.2967/jnumed.125.271421 ...
Journal of Nuclear Medicine March 2026, jnumed.125.271704; DOI: https://doi.org/10.2967/jnumed.125.271704 ...
Journal of Nuclear Medicine February 2026, jnumed.125.271098; DOI: https://doi.org/10.2967/jnumed.125.271098 ...
Journal of Nuclear Medicine January 2026, jnumed.125.269933; DOI: https://doi.org/10.2967/jnumed.125.269933 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results